Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells

Mesenchymal stem cell therapy (MSCT) for immune and inflammatory diseases continues to be popular based on progressive accumulation of preclinical mechanistic evidence. This has led to further expansion in clinical indications from graft rejection, autoimmune diseases, and osteoarthritis, to inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li‐Tzu, Liu, Ko‐Jiunn, Sytwu, Huey‐Kang, Yen, Men‐Luh, Yen, B. Linju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Concise Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380447/
https://www.ncbi.nlm.nih.gov/pubmed/34008922
http://dx.doi.org/10.1002/sctm.21-0021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380447/
https://www.ncbi.nlm.nih.gov/pubmed/34008922
http://dx.doi.org/10.1002/sctm.21-0021

Ejemplares similares